{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:41:48Z","timestamp":1791042108019,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2155 - 39087428"],"award-info":[{"award-number":["EXC 2155 - 39087428"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HO2402\/18-1 MSAomics"],"award-info":[{"award-number":["HO2402\/18-1 MSAomics"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["Nieders\u00e4chsisches Vorab"],"award-info":[{"award-number":["Nieders\u00e4chsisches Vorab"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is histopathologically defined by the presence of Lewy bodies, which are intracellular proteinaceous inclusions that contain mainly aggregated alpha-synuclein (aSyn). It is believed that oligomeric intermediates between monomeric aSyn and large aggregates are neurotoxic, which would lead to the demise of dopaminergic neurons. Therefore, novel therapies preventing aSyn-induced cell death need to be developed. Therefore, we performed a genome-wide siRNA screening in an aSyn-induced dopaminergic cell death model and found the knockdown of three transforming growth factor-beta (TGFb) pathway-related genes to be protective. Hence, we hypothesized that a reduction in TGFb signaling would protect dopaminergic neurons from aSyn-induced toxicity. Thus, we validated the results of the genome-wide knockdown screening with the use of two different types of siRNAs. We confirmed that the knockdown of Activin receptor-like kinase 5 (\n                    <jats:italic>ALK5<\/jats:italic>\n                    ) and Mothers against decapentaplegic homolog 2 (\n                    <jats:italic>SMAD2<\/jats:italic>\n                    ), two genes of the TGFb pathway, protected dopaminergic neurons from aSyn-induced toxicity. An increase in TGFb signaling by treatment with TGFb ligands further exacerbated aSyn-induced toxicity, whereas this effect was mitigated by knockdown of\n                    <jats:italic>ALK5<\/jats:italic>\n                    ,\n                    <jats:italic>SMAD2<\/jats:italic>\n                    , or Dynein light chain roadblock type-1 (\n                    <jats:italic>DYNLRB1<\/jats:italic>\n                    ). Moreover, TGFb ligand treatment induced an up-regulation of\n                    <jats:italic>SNCA<\/jats:italic>\n                    mRNA expression in aSyn-overexpressing cells. Interestingly, consistent with the literature, we identified an up-regulation of the genes of the TGFb pathway in aSyn-overexpressing cells. Altogether, we identified a potential protective role by interference with the TGFb pathway against aSyn-induced toxicity. These findings provide a rationale for the development of novel strategies against PD.\n                  <\/jats:p>","DOI":"10.1038\/s41420-025-02901-2","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:05:50Z","timestamp":1765548350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of TGF-beta signaling protects from alpha-synuclein induced toxicity"],"prefix":"10.1038","volume":"12","author":[{"given":"Oscar Wing Ho","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja Hanna","family":"Bothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Evsyukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Moebius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bickle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-0121","authenticated-orcid":false,"given":"Matthias","family":"H\u00f6llerhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397.","journal-title":"Lancet Neurol"},{"key":"2901_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 2024;23:191\u2013204.","journal-title":"Lancet Neurol"},{"key":"2901_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA. 1998;95:6469\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2901_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D. \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med. 2017;23:1\u201313.","journal-title":"Nat Med"},{"key":"2901_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z, et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun. 2022;13:5512.","journal-title":"Nat Commun"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem. 2002;277:38884\u201394.","journal-title":"J Biol Chem"},{"key":"2901_CR8","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","volume":"25","author":"J Lotharius","year":"2005","unstructured":"Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, et al. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci. 2005;25:6329\u201342.","journal-title":"J Neurosci"},{"key":"2901_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.neurobiolaging.2014.01.027","volume":"35","author":"M H\u00f6llerhage","year":"2014","unstructured":"H\u00f6llerhage M, Goebel JN, Andrade de A, Hildebrandt T, Dolga A, Culmsee C, et al. Trifluoperazine rescues human dopaminergic cells from wild-type \u03b1-synuclein-induced toxicity. Neurobiol Aging. 2014;35:1700\u201311.","journal-title":"Neurobiol Aging"},{"key":"2901_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40035-025-00486-5","volume":"14","author":"M H\u00f6llerhage","year":"2025","unstructured":"H\u00f6llerhage M, Duan L, Chua OWH, Moebius C, Bothe SH, Losse K, et al. A genome-wide RNA interference screening reveals protectiveness of SNX5 knockdown in a Parkinson\u2019s disease cell model. Transl Neurodegener. 2025;14:27.","journal-title":"Transl Neurodegener"},{"key":"2901_CR11","doi-asserted-by":"publisher","first-page":"a022053.","DOI":"10.1101\/cshperspect.a022053","volume":"8","author":"C-H Heldin","year":"2016","unstructured":"Heldin C-H, Moustakas A. Signaling receptors for TGF-\u03b2 family members. Cold Spring Harb Perspect Biol. 2016;8:a022053.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2901_CR12","doi-asserted-by":"publisher","first-page":"a022061.","DOI":"10.1101\/cshperspect.a022061","volume":"8","author":"A Hata","year":"2016","unstructured":"Hata A, Chen Y-G. TGF-\u03b2 signaling from receptors to Smads. Cold Spring Harb Perspect Biol. 2016;8:a022061.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2901_CR13","doi-asserted-by":"publisher","first-page":"a022145.","DOI":"10.1101\/cshperspect.a022145","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Alexander PB, Wang X-F. TGF-\u03b2 family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 2017;9:a022145.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1074\/jbc.M407939200","volume":"280","author":"CE Runyan","year":"2005","unstructured":"Runyan CE, Schnaper HW, Poncelet A-C. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J Biol Chem. 2005;280:8300\u20138.","journal-title":"J Biol Chem"},{"key":"2901_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0092-8674(00)81701-8","volume":"95","author":"T Tsukazaki","year":"1998","unstructured":"Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell. 1998;95:779\u201391.","journal-title":"Cell"},{"key":"2901_CR16","doi-asserted-by":"publisher","first-page":"a022079.","DOI":"10.1101\/cshperspect.a022079","volume":"8","author":"CS Hill","year":"2016","unstructured":"Hill CS. Transcriptional Control by the SMADs. Cold Spring Harb Perspect Biol. 2016;8:a022079.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1128\/MCB.24.21.9383-9389.2004","volume":"24","author":"H J\u00f6rnvall","year":"2004","unstructured":"J\u00f6rnvall H, Reissmann E, Andersson O, Mehrkash M, Ib\u00e1\u00f1ez CF. ALK7, a receptor for nodal, is dispensable for embryogenesis and left-right patterning in the mouse. Mol Cell Biol. 2004;24:9383\u20139.","journal-title":"Mol Cell Biol"},{"key":"2901_CR18","doi-asserted-by":"publisher","first-page":"19122","DOI":"10.1074\/jbc.M609915200","volume":"282","author":"Q Jin","year":"2007","unstructured":"Jin Q, Ding W, Mulder KM. Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway. J Biol Chem. 2007;282:19122\u201332.","journal-title":"J Biol Chem"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1101\/gad.1590908","volume":"22","author":"X Guo","year":"2008","unstructured":"Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang X-F. Axin and GSK3-control Smad3 protein stability and modulate TGF- signaling. Genes Dev. 2008;22:106\u201320.","journal-title":"Genes Dev"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.3390\/ijms13078219","volume":"13","author":"A Dobolyi","year":"2012","unstructured":"Dobolyi A, Vincze C, P\u00e1l G, Lovas G. The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci. 2012;13:8219\u201358.","journal-title":"Int J Mol Sci"},{"key":"2901_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2011.06.002","volume":"34","author":"K Krieglstein","year":"2011","unstructured":"Krieglstein K, Zheng F, Unsicker K, Alzheimer C. More than being protective: functional roles for TGF-\u03b2\/activin signaling pathways at central synapses. Trends Neurosci. 2011;34:421\u20139.","journal-title":"Trends Neurosci"},{"key":"2901_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00441-004-0920-8","volume":"318","author":"K Krieglstein","year":"2004","unstructured":"Krieglstein K. Factors promoting survival of mesencephalic dopaminergic neurons. Cell Tissue Res. 2004;318:73\u201380.","journal-title":"Cell Tissue Res"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00441-011-1278-3","volume":"347","author":"K Krieglstein","year":"2012","unstructured":"Krieglstein K, Miyazono K, Dijke P, ten, Unsicker K. TGF-\u03b2 in aging and disease. Cell Tissue Res. 2012;347:5\u20139.","journal-title":"Cell Tissue Res"},{"key":"2901_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","volume":"14","author":"K Krieglstein","year":"1995","unstructured":"Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 1995;14:736\u201342.","journal-title":"EMBO J"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1044-7431(03)00081-2","volume":"23","author":"A S\u00e1nchez-Capelo","year":"2003","unstructured":"S\u00e1nchez-Capelo A, Colin P, Guibert B, Biguet NF, Mallet J. Transforming growth factor beta1 overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice. Mol Cell Neurosci. 2003;23:614\u201325.","journal-title":"Mol Cell Neurosci"},{"key":"2901_CR26","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","volume":"37","author":"I Tesseur","year":"2017","unstructured":"Tesseur I, Nguyen A, Chang B, Li L, Woodling NS, Wyss-Coray T, et al. Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice. J Neurosci. 2017;37:4584\u201392.","journal-title":"J Neurosci"},{"key":"2901_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nn1816","volume":"10","author":"J Zhang","year":"2007","unstructured":"Zhang J, Pho V, Bonasera SJ, Holtzman J, Tang AT, Hellmuth J, et al. Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat Neurosci. 2007;10:77\u201386.","journal-title":"Nat Neurosci"},{"key":"2901_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106446","volume":"134","author":"Y Dong","year":"2023","unstructured":"Dong Y, Lu J, Zhang S, Chen L, Wen J, Wang F, et al. Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3\u03b2 inhibitors for the treatment of Alzheimer\u2019s disease. Bioorg Chem. 2023;134:106446.","journal-title":"Bioorg Chem"},{"key":"2901_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.69","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu Q, Qiu J, Liang M, Golinski J, van Leyen K, Jung JE, et al. Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis. 2014;5:e1084.","journal-title":"Cell Death Dis"},{"key":"2901_CR30","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1074\/jbc.M005200200","volume":"276","author":"H J\u00f6rnvall","year":"2001","unstructured":"J\u00f6rnvall H, Blokzijl A, Dijke Pten, Ib\u00e1\u00f1ez CF. The orphan receptor serine\/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line. J Biol Chem. 2001;276:5140\u20136.","journal-title":"J Biol Chem"},{"key":"2901_CR31","first-page":"2431","volume":"6","author":"HA Loomans","year":"2016","unstructured":"Loomans HA, Andl CD. Activin receptor-like kinases: a diverse family playing an important role in cancer. Am J Cancer Res. 2016;6:2431\u201347.","journal-title":"Am J Cancer Res"},{"key":"2901_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1006\/mcne.1996.0034","volume":"7","author":"K Tsuchida","year":"1996","unstructured":"Tsuchida K, Sawchenko PE, Nishikawa S, Vale WW. Molecular cloning of a novel type I receptor serine\/threonine kinase for the TGF beta superfamily from rat brain. Mol Cell Neurosci. 1996;7:467\u201378.","journal-title":"Mol Cell Neurosci"},{"key":"2901_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.yjmcc.2014.08.008","volume":"76","author":"KVT Engebretsen","year":"2014","unstructured":"Engebretsen KVT, Sk\u00e5rdal K, Bj\u00f8rnstad S, Marstein HS, Skrbic B, Sjaastad I, et al. Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. J Mol Cell Cardiol. 2014;76:148\u201357.","journal-title":"J Mol Cell Cardiol"},{"key":"2901_CR34","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/0008-5472.CAN-06-2389","volume":"67","author":"E Suzuki","year":"2007","unstructured":"Suzuki E, Kim S, Cheung H-K, Corbley MJ, Zhang X, Sun L, et al. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res. 2007;67:2351\u20139.","journal-title":"Cancer Res"},{"key":"2901_CR35","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1101\/gad.330837.119","volume":"33","author":"E Arag\u00f3n","year":"2019","unstructured":"Arag\u00f3n E, Wang Q, Zou Y, Morgani SM, Ruiz L, Kaczmarska Z, et al. Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-\u03b2 signaling. Genes Dev. 2019;33:1506\u201324.","journal-title":"Genes Dev"},{"key":"2901_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep21602","volume":"6","author":"L Liu","year":"2016","unstructured":"Liu L, Liu X, Ren X, Tian Y, Chen Z, Xu X, et al. Smad2 and Smad3 have differential sensitivity in relaying TGF\u03b2 signaling and inversely regulate early lineage specification. Sci Rep. 2016;6:21602.","journal-title":"Sci Rep"},{"key":"2901_CR37","first-page":"209","volume":"46","author":"K Krieglstein","year":"1995","unstructured":"Krieglstein K, Suter-Crazzolara C, Unsicker K. Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily. J Neural Transm Suppl. 1995;46:209\u201316.","journal-title":"J Neural Transm Suppl"},{"key":"2901_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s11010-022-04369-5","volume":"477","author":"H Kang","year":"2022","unstructured":"Kang H, Seo E, Oh YS, Jun H-S. TGF-\u03b2 activates NLRP3 inflammasome by an autocrine production of TGF-\u03b2 in LX-2 human hepatic stellate cells. Mol Cell Biochem. 2022;477:1329\u201338.","journal-title":"Mol Cell Biochem"},{"key":"2901_CR39","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2018.01364","volume":"9","author":"T Komai","year":"2018","unstructured":"Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, et al. Transforming Growth Factor-\u03b2 and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals. Front Immunol. 2018;9:1364.","journal-title":"Front Immunol"},{"key":"2901_CR40","doi-asserted-by":"publisher","first-page":"2464.","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan E-K, Chao Y-X. Historical perspective: models of Parkinson\u2019s disease. Int J Mol Sci. 2020;21:2464.","journal-title":"Int J Mol Sci"},{"key":"2901_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","volume":"235","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Bj\u00f6rklund A. Comparison of the behavioural and histological characteristics of the 6-OHDA and \u03b1-synuclein rat models of Parkinson\u2019s disease. Exp Neurol. 2012;235:306\u201315.","journal-title":"Exp Neurol"},{"key":"2901_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/380252a0","volume":"380","author":"DM Gash","year":"1996","unstructured":"Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, et al. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature. 1996;380:252\u20135.","journal-title":"Nature"},{"key":"2901_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/373335a0","volume":"373","author":"A Tomac","year":"1995","unstructured":"Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 1995;373:335\u20139.","journal-title":"Nature"},{"key":"2901_CR44","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/brain\/awr149","volume":"134","author":"M Decressac","year":"2011","unstructured":"Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, et al. GDNF fails to exert neuroprotection in a rat \u03b1-synuclein model of Parkinson\u2019s disease. Brain. 2011;134:2302\u201311.","journal-title":"Brain"},{"key":"2901_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awz023","volume":"142","author":"A Whone","year":"2019","unstructured":"Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, et al. Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease. Brain. 2019;142:512\u201325.","journal-title":"Brain"},{"key":"2901_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3940(95)11686-Q","volume":"193","author":"M Mogi","year":"1995","unstructured":"Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson\u2019s disease. Neurosci Lett. 1995;193:129\u201332.","journal-title":"Neurosci Lett"},{"key":"2901_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/exnr.1996.0200","volume":"142","author":"MP Vawter","year":"1996","unstructured":"Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson\u2019s disease in ventricular cerebrospinal fluid. Exp Neurol. 1996;142:313\u201322.","journal-title":"Exp Neurol"},{"key":"2901_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.25815","volume":"29","author":"GU H\u00f6glinger","year":"2014","unstructured":"H\u00f6glinger GU, Huppertz H-J, Wagenpfeil S, Andr\u00e9s MV, Belloch V, Le\u00f3n T, et al. Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. Mov Disord. 2014;29:479\u201387.","journal-title":"Mov Disord"},{"key":"2901_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone S, Boada M, Dubois B, H\u00fcll M, Rinne JO, Huppertz H-J, et al. A phase II trial of tideglusib in Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:75\u201388.","journal-title":"J Alzheimers Dis"},{"key":"2901_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Ma S, Chen J, Hu K, Li Y, Zhang Z, et al. GSK-3\u03b2 Contributes to Parkinsonian dopaminergic neuron death: evidence from conditional knockout mice and Tideglusib. Front Mol Neurosci. 2020;13:81.","journal-title":"Front Mol Neurosci"},{"key":"2901_CR51","first-page":"2099","volume":"29","author":"MP Rausch","year":"2009","unstructured":"Rausch MP, Hahn T, Ramanathapuram L, Bradley-Dunlop D, Mahadevan D, Mercado-Pimentel ME, et al. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer. Anticancer Res. 2009;29:2099\u2013109.","journal-title":"Anticancer Res"},{"key":"2901_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13311-022-01338-0","volume":"20","author":"F Richter","year":"2023","unstructured":"Richter F, Stanojlovic M, K\u00e4ufer C, Gericke B, Feja M. A mouse model to test novel therapeutics for Parkinson\u2019s disease: an update on the Thy1-aSyn (\u201cline 61\u201d) mice. Neurotherapeutics. 2023;20:97\u2013116.","journal-title":"Neurotherapeutics"},{"key":"2901_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.787059","volume":"13","author":"M H\u00f6llerhage","year":"2022","unstructured":"H\u00f6llerhage M, Stepath M, Kohl M, Pfeiffer K, Chua OWH, Duan L, et al. Transcriptome and proteome analysis in LUHMES cells overexpressing alpha-synuclein. Front Neurol. 2022;13:787059.","journal-title":"Front Neurol"},{"key":"2901_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2285-7","volume":"11","author":"T Chakroun","year":"2020","unstructured":"Chakroun T, Evsyukov V, Nyk\u00e4nen N-P, H\u00f6llerhage M, Schmidt A, Kamp F, et al. Alpha-synuclein fragments trigger distinct aggregation pathways. Cell Death Dis. 2020;11:84.","journal-title":"Cell Death Dis"},{"key":"2901_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneumeth.2016.07.011","volume":"271","author":"AJ Haas","year":"2016","unstructured":"Haas AJ, Prigent S, Dutertre S, Le Dr\u00e9an Y, Le Page Y. Neurite analyzer: an original Fiji plugin for quantification of neuritogenesis in two-dimensional images. J Neurosci Methods. 2016;271:86\u201391.","journal-title":"J Neurosci Methods"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02901-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:02:31Z","timestamp":1769184151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02901-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02901-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6867964\/v1","asserted-by":"object"}]},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}